Hauck, J. Spencer http://orcid.org/0000-0003-1722-8709
Moon, David
Jiang, Xue
Wang, Mu-En
Zhao, Yue
Xu, Lingfan
Quang, Holly http://orcid.org/0009-0008-4259-6718
Butler, William
Chen, Ming http://orcid.org/0000-0002-3470-1062
Macias, Everardo
Gao, Xia http://orcid.org/0000-0003-0979-9990
He, Yiping
Huang, Jiaoti http://orcid.org/0000-0003-1195-1998
Funding for this research was provided by:
Duke | Duke University School of Medicine | Duke Clinical Research Institute
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (PC200042)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA237618)
Cancer Prevention and Research Institute of Texas (PR210056)
Article History
Received: 7 July 2023
Accepted: 19 December 2023
First Online: 3 January 2024
Competing interests
: J.H. is a consultant for or owns shares in the following companies: Amgen, Artera, Kingmed Diagnostics, MoreHealth, OptraScan, York Biotechnology, Genecode, Seagen Inc. and Sisu Pharma, and received grants from Zenith Epigenetics, BioXcel Therapeutics, Inc., Dracen Pharmaceuticals and Fortis Therapeutics. All other authors declare no competing interests’.